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Toxigenic and nontoxigenic Vibrio cholerae 01, El Tor biotype strains, which are endemic to the U.S. Gulf
Coast, can be lysogenic for bacteriophage VcA-3. To evaluate the presence of VcA-3 as an indicator of
toxigenicity and as an epidemic strain marker, phage production and the presence of phage and cholera toxin
genes were assayed in 98 strains of V. cholerae 01 (35 U.S. and 63 foreign strains). By using a Hindlll
chromosomal digest for Southern blot analysis, 39 of the study strains hybridized with the VcA-3 probe in 10
banding patterns. The 15 toxigenic and 6 of the 20 nontoxigenic U.S. isolates gave four VcA-3-related patterns.
Among the foreign isolates, 12 of 12 toxigenic classical biotype strains, 1 of 43 toxigenic El Tor biotype strains,
and 3 of 8 nontoxigenic atypical strains gave six patterns that were clearly distinct from that of VcA-3.
Compared with Southern blot analysis, the phage production assay had a sensitivity of 1.0 and a specificity of
0.48, while the colony hybridization assay had a sensitivity of 1.0 and a specificity of 0.77 for identification of
VcA-3. Neither assay reliably identified the toxigenic Gulf Coast clone. The presence of VcA-3, as defined by
Southern blot analysis, always separated toxigenic U.S. from foreign isolates and often from nontoxigenic U.S.
isolates of V. cholerae 01.
Toxigenic Vibrio cholerae 01, the causative agent of
cholera, has traditionally been characterized by serotype
and biotype. Since the early 1960s, most isolates worldwide
have belonged to the El Tor biotype and either the Inaba or
Ogawa serotype. In 1984, the World Health Organization
issued a report (26) outlining the need for additional methods
for the subtyping of V. cholerae serogroup 01 isolates in
order to facilitate epidemiologic studies and implement con-
trol measures such as vaccines. Phenotypic tests such as
biotyping and phage typing have been used for subtyping in
the past. These are often affected by culture conditions or
problems of gene expression. The newer molecular tech-
niques now available to investigators (25) may identify
pathogenicity factors or at least provide more specific, stable
markers for pathogenic or epidemic strains. Genotypic tests
should overcome many of the limitations of phenotypic
assays and have the potential to be more specific and
sensitive.
Toxigenic V. cholerae 01 appears to have an environmen-
tal reservoir on the U.S. Gulf Coast and has caused well-
documented sporadic and epidemic disease since 1973 (2-4).
Kaper et al. (17) used a Southern blot analysis to demon-
strate that toxigenic strains of V. cholerae 01 from the Gulf
Coast had similar cholera toxin (CT) gene sequences and
concluded that a single strain of toxigenic V. cholerae 01 is
resident on the Gulf Coast. Epidemic investigations within
the United States have been complicated by the isolation of
nontoxigenic V. cholerae 01 from both patients and the
environment; the pathogenicities of these organisms and
their relationship to toxigenic strains are poorly understood
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and controversial (6). Furthermore, the relationship of the
toxigenic Gulf Coast clone to the current (seventh) cholera
pandemic remains unclear.
Goldberg and Murphy (14) reported that environmental
and clinical V. cholerae 01 strains isolated from the U.S.
Gulf Coast are lysogenic for a vibriophage which they
designated VcA-3. They demonstrated by Southern blot
analysis that all U.S. Gulf Coast clinical isolates carried
VcA-3 phage integrated in the same chromosomal location.
Later, Cook et al. (7) showed that classical biotype strains
isolated during the sixth pandemic and recently in Bang-
ladesh hybridized in Southern blots with vibriophage VcA-1
and had similar patterns, indicating similar integration sites
and clonality of that biotype. In this study, we expand the
work of Goldberg and Murphy (14) and also investigate the
use of phenotypic and colony blot hybridization assays as
epidemic strain markers for VcA-3.
MATERIALS AND METHODS
Bacteria. V. cholerae 01 strains were selected on the basis
of epidemiologic data, case reports, environmental surveys,
and geographic isolation site. Isolates were obtained from
the stock collection of the Enteric Diseases Laboratory
Section, Centers for Disease Control (CDC), and had been
received by the CDC between 1973 and 1988. A total of 98
study strains was selected (H, human source; E, environ-
mental source), as follows: 15 toxigenic strains (11 H; 4 E),
20 nontoxigenic strains (14 H; 6 E), 55 toxigenic foreign
strains (all H), and 8 nontoxigenic foreign strains (4 H; 4 E).
Phenotypic tests. Stock cultures of V. cholerae 01 were
examined for viability and purity and were then identified by
the appropriate biochemical tests (8). Slide agglutination was
used for the determination of the 01 serogroup and serotype
(22). Five traditional tests were used to define the classical
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and El Tor biotypes of V. cholerae (8). Several CT assays
were used and are described in detail in a previous report (1).
The test for production of vibriophage VcA-3 used V.
cholerae RJ1 (16) as an indicator strain and isolate 2164-78 as
a negative control. The two media used were TYC agar and
TYC semisolid medium. TYC medium contained tryptone
(Difco Laboratories, Detroit, Mich.), 10 g; yeast extract, 2 g;
glucose, 1 g; NaCl, 8 g; and endotoxin-free water to 1,000 ml
(pH 7.8). TYC agar contained 1.1% (wt/vol) agar, and TYC
semisolid medium contained 0.5% (wt/vol) agar. Two tubes,
each containing 3 ml of TYC semisolid medium, were
warmed until the medium was in a liquid state and held at
46°C. One tube received 0.2 ml of an overnight heart infusion
broth culture of indicator organism. The second tube re-
ceived the same amount of negative control organism. The
contents of each tube were mixed and poured over the
surface of deep (5-mm) TYC agar plates. Overnight cultures
of study isolates on Trypticase soy agar with 5% sheep blood
(BBL Microbiology Systems, Cockeysville, Md.) were
tested for production of VcA-3 phage by stabbing a tooth-
pick into the indicator strain and negative control overlays.
A known VcA-3 producer strain was included with each
batch of study isolates. The overlay plates were incubated
overnight at 36°C. The appearance of a plaque in the
indicator plate and the absence of clearing in the negative
control plate were indicative of VcA-3 production.
Chromosomal DNA preparation. Bacterial strains were
grown in brain heart infusion broth at 37°C to an A575 of 0.8
± 0.02. The cells were separated from the growth medium by
centrifugation and were resuspended in 1 ml of 50 mM Tris
buffer (pH 8.0, 25°C). The suspension was placed in a 1.5-ml
Eppendorf tube and centrifuged for 2 min at high speed in a
microcentrifuge. The supernatant was discarded, and the
cells were suspended in 150 ,ul of sucrose solution (50 mM
Tris buffer [pH 8.0, 5°C] and 25% sucrose); 50 ,ll of lyso-
zyme solution (5 mg of lysozyme per ml in 0.25 M Tris buffer
[pH 8.0, 5°C]) was added, and the tube was placed on ice for
15 min. Then, 60 ,ul of 0.2 M EDTA (pH 8.0) was added and
incubated for 5 min on ice. A mixture consisting of 10 ,ul of
1 mg of RNase per ml in 50 mM Tris buffer (pH 8.0, 25°C),
50 pR1 of 25 mg of pronase per ml in 50 mM Tris buffer (pH
8.0, 25°C), and 250 pI of lysis mixture (10 mM EDTA, 2%
Triton X-100, 50 mM Tris buffer [pH 8.0, 25°C]) was added;
and the tube was placed in a 37°C incubator for 90 min. This
was followed by phenol-chloroform extraction. The purified
DNA was recovered by ethanol precipitation and dissolved
in a suitable volume of sterile distilled water. A 2-,ug amount
of DNA was digested with HindIII, according to the instruc-
tions of the manufacturer (New England Biolabs, Inc.,
Beverly, Mass.). After normal incubation, an additional 1 plI
of Hindlll was added, and the tubes were incubated for an
additional 2 h.
Digests were electrophoresed through a horizontal 1%
agarose (Seakem GTG, FMC Bioproducts, Rockland,
Maine) gel (20) at 65 V in TBE buffer (89 mM Tris base, 2.5
mM disodium EDTA, 89 mM boric acid) for 18 h. Gels were
stained with ethidium bromide (0.4 pug/ml) for 20 min and
visualized by UV transillumination. The method of Southern
(23) was used to transfer DNA fragments from the agarose
gel onto a nitrocellulose membrane.
Bacterial colony DNA was prepared for hybridization by
the method of Maas (18). Whatman 541 filter papers were
kept at room temperature without light until hybridization.
Preparation of DNA probe for CT. The oligonucleotide
probe (ctxall) for the CT gene was produced on a model
380A polynucleotide synthesizer (Applied Biosystems, Fos-
ter City, Calif.) and was provided through the courtesy of
Brian Holloway, Biotechnology Core Facility Branch, CDC.
The ctxall probe encodes amino acids 45 through two-thirds
of amino acid 51 (Ala, Arg, Gly, Thr, Gly, Thr, and the GG
sequence of Gly). The exact nucleotide sequence is 5'-
GCAAGAGGAACTCAGACGGG-3' (generously provided
by Walter Hill, Division of Microbiology, U.S. Food and
Drug Administration, Washington, D.C.). The probe was
lyophilized for storage and rehydrated with sterile distilled
water before end-labeling with bacteriophage T4 polynucle-
otide kinase (20 U/,ul; Bethesda Research Laboratories,
Gaithersburg, Md.). Unincorporated 32p was removed by
using a NACS PREPAC column (Bethesda Research Labo-
ratories) and by eluting the labeled probe with 4.0 M
ammonium acetate buffer.
Preparation of VcA-3 phage DNA probe. Phage was pre-
pared, concentrated, and assayed by the method of Gerdes
and Romig (12, 13). Phage VcA-3 DNA was purified by
phenol extraction and ethanol precipitation and was stored
at 4°C. The phage DNA was labeled with [ct-32P]dCTP by
random priming following the instructions of the manufac-
turer (Boehringer GmbH, Mannheim, Federal Republic of
Germany) (10, 11). Unincorporated 32p was removed by
binding the DNA to a NICK column (Pharmacia AB, Upp-
sala, Sweden) prepacked with Sephadex G-50.
Hybridization. For CT probe assays, nitrocellulose mem-
branes were hybridized with ctxall overnight at 40°C in a
solution containing 50 ml of hybridization mixture (15 ml of
20x SSC [lx SSC is 0.15 M NaCl plus 0.015 M sodium
citrate], 5 ml of 5Ox Denhardt's solution [2 g of Ficoll, 2 g of
polyvinylpyrrolidone, and 2 g of bovine serum albumin in
200 ml of distilled water, stored at -20°C in 5-ml aliquots],
0.1 ml of 0.5 M EDTA [pH 8.0], and 28.9 ml of distilled
water), 1 ml of sonicated and boiled calf thymus DNA (10
mg/ml), and 106 cpm of labeled probe. Membranes were
rinsed with 6x SSC, washed with fresh 6x SSC at 50°C for
1 h (twice), and finally rinsed with 2x SSC (19).
For VcA-3 probe assays, nitrocellulose membranes and
Whatman 541 filters were hybridized with 5 x 106 cpm of
labeled VcA-3 DNA as described previously (7). Membranes
and filters for both probes were exposed to X-ray film
overnight at -70°C.
RESULTS
In Southern blot analysis, 39 of the 98 study isolates (40%)
hybridized with the VcA-3 DNA probe, yielding 10 different
hybridization patterns (patterns i to x). Figure 1 shows
representative VcA-3 patterns. Table 1 lists the types and
numbers of study strains associated with each pattern.
All 12 classical biotype isolates hybridized with the
vibriophage probe in one pattern (pattern i) that indicated the
presence of VcA-1 (7). This pattern was not seen in nonclas-
sical isolates. Previous studies have documented that VcA-1
and VcA-3 are similar morphologically and are homoimmune
(14).
Each of the 15 toxigenic U.S. isolates hybridized with
VcA-3 DNA, yielding three different hybridization patterns
(pattern ii, 13 strains; pattern iii, 1 strain; pattern vii, 1
strain). Pattern ii is similar to that described previously (14)
for VcA-3 and represents the prototype pattern in this study.
Patterns iii and vii each differed from the predominant
pattern ii only by the addition of a single band in the
high-molecular-weight region. Pattern viii, seen in one non-
toxigenic U.S. El Tor isolate, also differed from pattern ii by
one high-molecular-weight band. These minor variations in
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FIG. 1. Autoradiograph of HindIII-digested chromosomal DNA
hybridized with the VcA-3 probe. Lane A, ATCC 14035 (9060-79)
(pattern i); lane B, 2164-78 (pattern ii); lane C, 3242-73 (pattern ii);
lane D, E9120 (pattern iv); lane E, 1074-78 (pattern v); lane F, 884-82
(pattern vi); lane G, 2373-81 (pattern vii); lane H, 2496-85 (pattern
ii); lane I, 2496-86 (pattern viii); lane J, bacteriophage lambda DNA;
lane K, 2538-86 (pattern iii), lane L, 2527-86 (pattern ix); lane M,
2584-87 (pattern x).
hybridization patterns probably reflect differences in the
VcA-3 phage insertion sites. Strains with these four related
hybridization patterns (patterns ii, iii, vii, viii) were also
positive in colony blot assays and in the phenotypic test for
VcA-3 phage production. For these reasons patterns iii, vii,
and viii were all considered to be VcA-3 (pattern ii) related.
Patterns iv, v, vi, and ix (found in one strain each) and
pattern x (found in two strains) were clearly different from
patterns i or ii. Five of the six strains with these patterns
were nontoxigenic, and three were negative in tests for
VcA-3 production. These five patterns appear to be more
TABLE 1. VcA-3 DNA hybridization patterns in
39 V. cholerae 01 isolates
Pattern No. of No. of isolate
designation bands and description
i 9 12 toxigenic classical strains
iia 9 13 toxigenic U.S. El Tor strains, 4
nontoxigenic U.S. El Tor strains
iiia 10 1 toxigenic U.S. El Tor strain
iv 7 1 toxigenic foreign El Tor strain
v 8 1 nontoxigenic atypical foreign strain
vi 8 1 nontoxigenic atypical U.S. strain
viia 10 1 toxigenic U.S. El Tor strain, 1
nontoxigenic U.S. El Tor strain
viiia 10 1 nontoxigenic U.S. El Tor strain
ix 6 1 nontoxigenic U.S. El Tor strain
x 9 2 nontoxigenic foreign El Tor strains
a VcA-3 and related patterns.
TABLE 2. VcA-3 DNA hybridization patterns in 58 U.S. and
foreign toxigenic V. cholerae 01 El Tor isolates
No. (%) of:
VcA-3 probe
pattern U.S. strains Foreign strains
(n = 15) (n = 43)
Negative 0 42 (98)
i 0 0
iia 13 (87) 0
iiia 1 (6.5) 0
iv 0 1 (2)
v 0 0
vi 0 0




a VcA-3 and related patterns.
distantly related to VcA-3 and VcA-1 and probably represent
distinct and separate vibriophages.
Minor differences of one or two restriction fragments with
VcA-3 hybridization patterns were predicted, since vibrio-
phage VcA-3 is capable of integrating without classic recom-
bination into different sites in the bacterial chromosome.
This lysogeny can inactivate the particular gene into which
the prophage has integrated (14). No correlation was noted
between a phenotypic change, e.g., toxin production or
biochemical reaction, and a variation of patterns iii, vii, and
viii from VcA-3 prototype pattern ii. There were also no
pattern-associated differences by year of isolation or geo-
graphic isolation site.
Table 2 shows the distribution of VcA-3 DNA probe
hybridization patterns among the toxigenic El Tor isolates.
The 15 U.S. isolates yielded three VcA-3 and related hybrid-
ization patterns (patterns ii, iii, and vii). The single foreign
toxigenic El Tor strain (E9120) that hybridized with the
VcA-3 probe in this analysis was isolated in Indonesia and
had a unique hybridization pattern (pattern iv) that was
clearly different from that of VcA-3 and related patterns. In
summary, none of the toxigenic foreign El Tor strains
yielded a VcA-3-related hybridization pattern. Therefore,
the presence of VcA-3 and related hybridization patterns
correlated 100% with U.S. toxigenic El Tor isolates (P <
0.0001 by Fisher's exact test) when U.S. and foreign toxi-
genic El Tor study strains were compared.
Table 3 shows that the VcA-3 production assay results
disagreed with VcA-3 and related hybridization patterns in
40 of the 98 (41%) strains tested. The majority of disagree-
TABLE 3. Correlation of VcA-3 phage production with VcA-3
and related hybridization patterns (patterns ii, iii, vii,
and viii) in 98 strains of V. cholerae 01
No. of isolates
Region and Phage Probe No. of
toxigenicitya (n) production pattern medntis
+ - + _
U.S., tox. (15) 15 0 15 0 0
U.S., nontox. (20) 6 14 6 14 0
Foreign, tox. (55) 38 17 0 55 38
Foreign, nontox. (8) 2 6 0 8 2
a nontox., nontoxigenic; tox., toxigenic.
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TABLE 4. Correlation of VcA-3 colony hybridization with VcA-3
and related hybridization patterns (patterns ii, iii, vii,
and viii) in 98 strains of V. cholerae 01
No. of isolates
Region and No. of
toxigenicitya (n) Colony Pattern disagree-ments
+ - + -
U.S., tox. (15) 15 0 15 0 0
U.S., nontox. (20) 8 12 6 14 2
Foreign, tox. (55) 13 42 0 55 13
Foreign, nontox. (8) 3 5 0 8 3
a nontox., nontoxigenic; tox., toxigenic.
ments involved toxigenic foreign El Tor strains in which the
VcA-3 production test result was positive yet in which no
hybridization occurred with the VcA-3 DNA probe. This
suggests that these plaques that were formed in the produc-
tion test were caused by one or more phages that were
genetically unrelated to VcA-3. The sensitivity of the VcA-3
production test compared with the hybridization pattern was
1.00; the specificity was 0.48. The accuracy of the VcA-3
production test compared with that of the "gold standard"
(i.e., the VcA-3-related hybridization pattern) was 59% (58
of 98 isolates).
Table 4 shows that colony blot test results disagreed with
VcA-3 and related hybridization patterns in 18 of the 98
(18%) strains tested. The sensitivity of the colony blot probe
assay compared with that of the Southern blot procedure
was 1.0, and the specificity was 0.77.
All 15 toxigenic U.S. El Tor strains produced plaques in
the phenotypic test and were positive for VcA-3 by DNA
probe. Thirty percent (6 of 20) of nontoxigenic U.S. isolates
were positive for VcA-3 in the production test and for VcA-3
and related hybridization patterns. The correlation observed
between toxigenicity and VcA-3 hybridization patterns as
well as phage production in U.S. strains was statistically
significant (P < 0.0001 by Fisher's exact test). Additionally,
the correlation between toxigenicity in these 35 U.S. strains
and colony hybridization with the VcA-3 DNA probe was
statistically significant (P = 0.0002 by Fisher's exact test).
DISCUSSION
Farmer et al. (9) suggested that the VcA-3 production test
be used as a screening test for the U.S. toxigenic V. cholerae
01 strain. Our data show a statistically significant correla-
tion between toxigenicity in the U.S. study strains and
VcA-3 production. When U.S. strains were tested for VcA-3
production and probed for CT genes, the results agreed for
29 of 35 (83%) strains.
Forty of 63 (63%) foreign El Tor strains from the current
pandemic produced plaques in the production assay, yet
only 16 were probe positive, and none had the VcA-3-related
hybridization pattern. On the basis of these results, the
VcA-3 production test is not a good indicator of the Gulf
Coast clone. Despite the correlation between VcA-3 produc-
tion and toxigenicity observed within the U.S. strains,
production was not a reliable indicator of toxigenicity. The
overall accuracy of the VcA-3 production test with respect
to the CT probe for all 98 study strains was relatively low.
Therefore, it appears that this phenotypic test may be useful
only for testing U.S. isolates from persons with no foreign
travel history.
Colony blot hybridization (15) was no better than the
VcA-3 production test as an indicator of toxigenicity. The
VcA-3 colony blot assay agreed with the CT probe results
for 27 of 35 (77%,) U.S. strains tested. When foreign strains
were tested, the colony blot results agreed with the toxin
probe results for only 18 of 63 strains. The colony blot probe
assay did not prove to be a useful test for identifying the Gulf
Coast clone. Although all 15 U.S. toxigenic strains were
positive, 16 foreign strains (13 toxigenic, 3 nontoxigenic)
tested positive as well. The colony blot probe assay did
differentiate U.S. toxigenic strains from most of the foreign
toxigenic strains that were positive in the production assay.
Southern blot analysis appears to be the most accurate
method of defining the VcA-3 phage (gold standard). In this
study, all the toxigenic U.S. isolates (n = 15) and 6 of the
nontoxigenic U.S. isolates (n = 20) yielded VcA-3 and
related hybridization patterns. These results are in agree-
ment with those of Goldberg and Murphy (14) in suggesting
that there is a clonal relationship among certain toxigenic
and nontoxigenic strains isolated from the U.S. Gulf Coast.
Morris et al. (21) also concluded that certain nontoxigenic
and toxigenic V. cholerae 01 strains from the Gulf Coast are
related. We further documented the presence of nontoxi-
genic V. cholerae 01 strains from both humans (n = 4) and
the environment (n = 1) that appeared to be unrelated to the
Gulf Coast clone. The hybridization pattern always sepa-
rated the Gulf Coast clone from foreign strains. No foreign
strain, either toxigenic or nontoxigenic, had a VcA-3 or
related hybridization pattern.
Chen et al. (6) used multilocus enzyme electrophoresis to
examine genetic relationships among toxigenic and nontox-
igenic V. cholerae 01 isolates obtained from patients and the
environment on the Gulf Coast. Their results support the
hypothesis that the Gulf Coast strains belong to a unique
"clone" (electrophoretic type) which contains toxigenic and
some nontoxigenic isolates. The current epidemic of cholera
in South America is caused by a strain of toxigenic V.
cholerae 01 that can be easily distinguished from Gulf Coast
isolates by phage production or colony hybridization (5).
Like most of the seventh pandemic strains, it is VcA-3
negative (24). It seems that even these simple, yet less
accurate, assays can be useful in specific circumstances.
Certainly, Southern blot analysis of VcA-3 is the most
accurate and epidemiologically useful molecular subtyping
technique.
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